Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. 1238P AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients
  1. Home
  2. Publications
  3. 1238P AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients

1238P AUTOMAN: A phase Ib/IIa study of osimertinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients

Authors:
  • BHB. Han
    B. Han
  • BYB. Yan
    B. Yan
  • AGA. Gu
    A. Gu
  • TCT. Chu
    T. Chu
  • WZW. Zhang
    W. Zhang
  • HWH. Wang
    H. Wang
  • HZH. Zhong
    H. Zhong
  • C. Shi
    C. Shi
  • XZX. Zhang
    X. Zhang

Publisher website
Google Scholar
  • 1 September 2021
    • journal article
    • abstracts
    • Published by Elsevier in Annals of Oncology
    • Vol. 32, S977
    • DOI:10.1016/j.annonc.2021.08.1843
Abstract
No abstract available
Keywords
  • OSIMERTINIB
Cited by 2 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.